Related references
Note: Only part of the references are listed.Significance of PGP9.5 Expression in Cancer-Associated Fibroblasts for Prognosis of Colorectal Carcinoma
Yuri Akishima-Fukasawa et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
The therapeutic potential of deubiquitinating enzyme inhibitors
Frederic Colland
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Jian Yuan et al.
CELL (2010)
CYLD: a tumor suppressor deubiquitinase regulating NF-kappa B activation and diverse biological processes
S-C Sun
CELL DEATH AND DIFFERENTIATION (2010)
USP11 negatively regulates TNFα-induced NF-κB activation by targeting on IκBα
Wenjing Sun et al.
CELLULAR SIGNALLING (2010)
Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer
Yan Long Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling
S. Hussain et al.
LEUKEMIA (2010)
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Martin Schwickart et al.
NATURE (2010)
FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination
Sirio Dupont et al.
CELL (2009)
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Mathew E. Sowa et al.
CELL (2009)
DUBs and cancer The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors
Sajjad Hussain et al.
CELL CYCLE (2009)
USP9X Enhances the Polarity and Self-Renewal of Embryonic Stem Cell-derived Neural Progenitors
Lachlan A. Jolly et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Gcn5 and SAGA Regulate Shelterin Protein Turnover and Telomere Maintenance
Boyko S. Atanassov et al.
MOLECULAR CELL (2009)
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor
S. Confalonieri et al.
ONCOGENE (2009)
Regulation of ErbB2 Receptor Status by the Proteasomal DUB POH1
Han Liu et al.
PLOS ONE (2009)
Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and β-Catenin/TCF Signaling
Anjali Bheda et al.
PLOS ONE (2009)
Strategies for the identification of novel inhibitors of deubiquitinating enzymes
Seth J. Goldenberg et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression
Adam S. Adler et al.
CANCER RESEARCH (2008)
Proteasome inhibitors in cancer therapy: Lessons from the first decade
Robert Z. Orlowski et al.
CLINICAL CANCER RESEARCH (2008)
Roles for CSN5 in control of p53/MDM2 activities
Xiao-Chun Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression
Xiao-Yong Zhang et al.
MOLECULAR CELL (2008)
Breast cancer metastases are molecularly distinct from their primary tumors
M. Vecchi et al.
ONCOGENE (2008)
A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway
Martin A. Cohn et al.
MOLECULAR CELL (2007)
The deubiquitinating enzyme USP11 controls an IκB kinase α(IKKα)-p53 signaling pathway in response to tumor necrosis factor α(TNFα)
Tomoko Yamaguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CYLD - A multifunctional deubiquitinase
Marcus Glittenberg et al.
FLY (2007)
β-catenin signaling in biological control and cancer
Nancy Gavert et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3β activity and associates with poor prognosis in human breast cancer
Qingqing Ding et al.
CANCER RESEARCH (2007)
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Riccardo Fodde et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
A requirement of FancL and FancD2 monoubiquitination in DNA repair
Sohsuke Seki et al.
GENES TO CELLS (2007)
Up-regulation of expression of the Ubiquitin Carboxyl-Terminal Hydrolase L1 gene in human airway epithelium of cigarette smokers
Brendan J. Carolan et al.
CANCER RESEARCH (2006)
Frequent alterations in the expression of serine/threonine kinases in human cancers
Maria Capra et al.
CANCER RESEARCH (2006)
A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response
Dong Zhang et al.
CELL (2006)
Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features
A Osoegawa et al.
CANCER (2006)
The 19 S proteasomal subunit POH1 contributes to the regulation of c-Jun ubiquitination, stability, and subcellular localization
Joseph F. Nabhan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Riding the DUBway: regulation of protein trafficking by deubiquitylating enzymes
Susan M. Millard et al.
JOURNAL OF CELL BIOLOGY (2006)
Role of ubiquitylation in cellular membrane transport
O Staub et al.
PHYSIOLOGICAL REVIEWS (2006)
Regulation of monoubiquitinated PCNA by DUB autocleavage
TT Huang et al.
NATURE CELL BIOLOGY (2006)
Pfam: clans, web tools and services
Robert D. Finn et al.
NUCLEIC ACIDS RESEARCH (2006)
A genomic and functional inventory of deubiquitinating enzymes
SMB Nijman et al.
CELL (2005)
A cancer-specific transcriptional signature in human neoplasia
F Nicassio et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Shelterin: the protein complex that shapes and safeguards human telomeres
T de Lange
GENES & DEVELOPMENT (2005)
Death-from-cancer signatures and stem cell contribution to metastatic cancer
GV Glinsky
CELL CYCLE (2005)
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
S Wuillème-Toumi et al.
LEUKEMIA (2005)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway
SMB Nijman et al.
MOLECULAR CELL (2005)
The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and β-catenin
RZ Murray et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions
D Ivan et al.
MODERN PATHOLOGY (2004)
JAMM: A metalloprotease-like zinc site in the proteasome and signalosome
XI Ambroggio et al.
PLOS BIOLOGY (2004)
The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity
B Burnett et al.
HUMAN MOLECULAR GENETICS (2003)
Proliferating cell nuclear antigen (PCNA):: a dancer with many partners
G Maga et al.
JOURNAL OF CELL SCIENCE (2003)
Otubains: a new family of cysteine proteases in the ubiquitin pathway
MY Balakirev et al.
EMBO REPORTS (2003)
Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome
R Verma et al.
SCIENCE (2002)
A cryptic protease couples deubiquitination and degradation by the proteasome
TT Yao et al.
NATURE (2002)
Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer
H Sasaki et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2001)
A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14
A Borodovsky et al.
EMBO JOURNAL (2001)
A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae
KS Makarova et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)